{"schema_version":"secwatch.filing_event.v1","accession":"0001034842-26-000007","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2026-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.432131+00:00","generated_at":"2026-05-16T05:13:19.751324+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Rigel appoints Michael P. Miller to board, effective Feb 1, 2026","bullets":["Michael P. Miller appointed to Rigel board effective Feb 1, 2026; term expires at 2027 annual meeting.","Miller will serve on Compensation Committee; receives $50k annual retainer plus $10k for committee.","Initial option grant of 12,000 shares under 2018 Plan; annual grants of 3,000 options + 2,500 RSUs thereafter.","Board determined Miller is independent under applicable standards; no family relationships or transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001034842-26-000007","json":"https://secwatch.observer/filing/0001034842-26-000007.json","markdown":"https://secwatch.observer/filing/0001034842-26-000007.md","text":"https://secwatch.observer/filing/0001034842-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000103484226000007/0001034842-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000103484226000007/rigl-20260201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:13:19.751324+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}